Clinical embryonic stem cell trials are set to begin in China, according to Nature News.
In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.
Protein researcher and former Whitehead Institute director Susan Lindquist has died.
In PNAS this week: work toward a CRISPR/Cas9-based approach to treat beta-thalassemia or sickle cell disease, bacteriophages uncovered in human stool, and more.
The study will screen patients using a combination of genotyping and wireless sensors to develop a better diagnostic method.
The firms said their test will be developed to detect levels of the tau protein that can leak into a person's bloodstream after head trauma or injury.
The NIH is seeking grant applications for projects focused on discovering biomarkers in Parkinson's disease and other Parkinsonian syndromes.
IO Informatics has begun beta testing a new iteration of the Sentient software suite with pharma partners ahead of a formal launch planned for the first quarter of 2016.
The test is based on a technology developed by an Amprion co-founder for the amplification of prions.
In two recent deals with 23andMe and Human Longevity, Genentech is planning to sequence thousands of genomes in order to learn more about diseases and inform therapeutic development.
Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.
Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.
In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.
Iceland has nearly eliminated Down syndrome from its population, CBS News reports.